Effect of Adding Dexmedetomidine versus Fentanyl to Intrathecal Bupivacaine on Spinal Block Characteristics in Gynecological Procedures: A Double Blind Controlled Study

Problem statement: The purpose of this study was to evaluate the onset and duration of sensory and motor block as well as operative analgesia and adverse effects of Dex Metedo Midine (DXM) or fentanyl given intrathecally with plain 0.5% bupivacaine for spinal anesthesia. Approach: seventy six patients classified as American Society of Anesthesiologists (ASA) status I, II and III scheduled for vaginal hysterectomy, vaginal wall repair and tension free vaginal tape were prospectively studied. Patients were randomly allocated to receive intrathecally either 10 mg isobaric bupivacaine plus 5 µg dexmetedomidine (group D n = 38) or 10 mg isobaric bupivacaine plus 25 mg fentanyl (group F n = 38), the onset time to reach peak sensory and motor level, the regression time for sensory and motor block, hemodynamic changes, and side effects were recorded. Results: Patients in group D had significant longer sensory and motor block times than patients in group F. the mean time of sensory regression to S1 was 274±73 min in group D and 179±47 min in group F (P < 0.001). The regression time of motor block to reach modified Bromage 0 was 240±60 min in group D and 155±46 min in group F (P< 0.001). The onset times to reach T10 dermatome and to reach peak sensory level as well as onset time to reach modified Bromage 3 motor block were not significantly different between the two groups. Conclusion: In women undergoing vaginal reconstructive surgery under spinal analgesia, 10 mg plain bupivacaine supplemented with 5 µg dexmetedomidine produces prolonged motor and sensory block compared with 25 µg fentanyl.

[1]  P. Bromage.  A Comparison of the Hydrochloride and Carbon Dioxide Salts of Lidocaine and Prilocaine in Epidural Analgesia , 1965, Acta anaesthesiologica Scandinavica. Supplementum.

[2]  U. Schambra,et al.  alpha 2-Adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha 2-adrenergic receptor subtypes at four distinct levels. , 1995, Brain research. Molecular brain research.

[3]  C. Touboul,et al.  Dose‐Related Prolongation of Hyperbaric Tetracaine Spinal Anesthesia by Clonidine in Humans , 1989, Anesthesia and analgesia.

[4]  H. Vaghadia,et al.  Small-Dose Hypobaric Lidocaine-Fentanyl Spinal Anesthesia for Short Duration Outpatient Laparoscopy. II. Optimal Fentanyl Dose , 1997, Anesthesia and analgesia.

[5]  G. Cooper,et al.  The influence of intrathecal fentanyl on the characteristics of subarachnoid block for Caesarean section , 1998, Anaesthesia.

[6]  T. Archer,et al.  Antinociceptive Effects and Spinal Cord Tissue Concentrations after Intrathecal Injection of Guanfacine or Clonidine into Rats , 1987, Anesthesia and analgesia.

[7]  A. Bader,et al.  Perioperative analgesia with subarachnoid fentanyl-bupivacaine for cesarean delivery. , 1989, Anesthesiology.

[8]  C. Palmer,et al.  Subarachnoid Fentanyl Augments Lidocaine Spinal Anesthesia for Cesarean Delivery , 1994, Regional Anesthesia & Pain Medicine.

[9]  J. Racle,et al.  Prolongation of Isobaric Bupivacaine Spinal Anesthesia with Epinephrine and Clonidine for Hip Surgery in the Elderly , 1987, Anesthesia and analgesia.

[10]  L. Niemi.  Effects of intrathecal clonidine on duration of bupivacaine spinal anaesthesia, haemodynamics, and postoperative analgesia in patients undergoing knee arthroscopy. , 1994, Acta anaesthesiologica Scandinavica.

[11]  R. Seewal,et al.  Effect of Addition of Various Doses of Fentanyl Intrathecally to 0.5% Hyperbaric Bupivacaine on Perioperative Analgesia and Subarachnoid-Block Characteristics in Lower Abdominal Surgery: A Dose-Response Study , 2006, Regional Anesthesia & Pain Medicine.

[12]  D. Bylund,et al.  α-2A Is the Predominant α-2 Adrenergic Receptor Subtype in Human Spinal Cord , 1992 .

[13]  U. Schambra,et al.  α1-Adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding α1-adrenergic receptor subtypes at four distinct levels , 1995 .

[14]  G. Gebhart,et al.  Antinociceptive effects of intrathecal adrenoceptor agonists in a rat model of visceral nociception. , 1990, The Journal of pharmacology and experimental therapeutics.

[15]  J. Neal,et al.  Fentanyl Prolongs Lidocaine Spinal Anesthesia Without Prolonging Recovery , 1995, Anesthesia and analgesia.

[16]  T. Yaksh.  Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing , 1985, Pharmacology Biochemistry and Behavior.

[17]  E. Kalso,et al.  Spinal Antinociception by Dexmedetomidine, a Highly Selective α2-Adrenergic Agonist , 1991 .

[18]  L. NlEMI.  Effects of intrathecal clonidine on duration of bupivacaine spinal anaesthesia, haemodynamics, and postoperative analgesia in patients undergoing knee arthroscopy , 1994 .

[19]  J. Eisenach,et al.  Alpha sub 2 -Adrenergic Agonists for Regional Anesthesia: A Clinical Review of Clonidine (1984 - 1995) , 1996, Anesthesiology.

[20]  Harbhej Singh,et al.  Intrathecal fentanyl prolongs sensory bupivacaine spinal block , 1995, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[21]  R. Fragen,et al.  Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults age 55 to 70 years. , 1999, Journal of clinical anesthesia.

[22]  R. Venn,et al.  Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. , 2001, British journal of anaesthesia.

[23]  M. Maze,et al.  Alpha-2B adrenoceptor activation inhibits a nociceptive response in the spinal cord of the neonatal rat , 1990 .

[24]  D. Choi,et al.  Bupivacaine‐Sparing Effect of Fentanyl in Spinal Anesthesia for Cesarean Delivery , 2000, Regional anesthesia and pain medicine.

[25]  A. Bader,et al.  Perioperative Analgesia with Subarachnoid Sufentanil Administration , 1992, Regional Anesthesia & Pain Medicine.

[26]  G. Wilcox,et al.  Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine. , 1999, The Journal of pharmacology and experimental therapeutics.

[27]  A. Santos,et al.  Incidence of Visceral Pain during Cesarean Section: The Effect of Varying Doses of Spinal Bupivacaine , 1989, Anesthesia and analgesia.

[28]  G. Ramsay,et al.  The Role of the α2-Adrenoceptor Agonist Dexmedetomidine in Postsurgical Sedation in the Intensive Care Unit , 2003 .

[29]  S. Alahuhta,et al.  Visceral pain during caesarean section under spinal and epidural anaesthesia with bupivacaine , 1990 .

[30]  P. Lavand'homme,et al.  Intrathecal Ropivacaine and Clonidine for Ambulatory Knee Arthroscopy: A Dose–Response Study , 2001, Anesthesiology.

[31]  T. Yaksh,et al.  Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. , 1981, Anesthesiology.

[32]  K. Omote,et al.  Effects of morphine on neuronal and behavioural responses to visceral and somatic nociception at the level of sinal cord , 1994, Acta anaesthesiologica Scandinavica.

[33]  H. Helenius,et al.  The Use of Bupivacaine and Fentanyl for Spinal Anesthesia for Urologic Surgery , 2000, Anesthesia and analgesia.

[34]  F. Lublin,et al.  Tizanidine treatment of spasticity caused by multiple sclerosis: Results of a double‐blind, placebo‐controlled trial , 1994, Neurology.

[35]  A. Baraka,et al.  Effect of low‐dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block , 2006, Acta anaesthesiologica Scandinavica.

[36]  E. Hamber,et al.  Intrathecal lipophilic opioids as adjuncts to surgical spinal anesthesia. , 1999, Regional anesthesia and pain medicine.

[37]  L. Kitahata,et al.  Visceral antinociceptive effects of spinal clonidine combined with morphine, [D-Pen2, D-Pen5] enkephalin, or U50,488H. , 1995, Anesthesiology.